|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0026845,
umls-concept:C0087111,
umls-concept:C0205420,
umls-concept:C0243005,
umls-concept:C0282460,
umls-concept:C0332174,
umls-concept:C0392752,
umls-concept:C0445550,
umls-concept:C0684224,
umls-concept:C0851346,
umls-concept:C1334281,
umls-concept:C1518578,
umls-concept:C1705294
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-10-18
|
|
pubmed:abstractText |
To determine the feasibility, toxicity, and clinical effectiveness of concurrent weekly cisplatin chemotherapy in conjunction with definitive radiation in the treatment of localised muscle invasive bladder cancer.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0167-8140
|
|
pubmed:author |
pubmed-author:BerryMartin PMP,
pubmed-author:DuchesneGillian MGM,
pubmed-author:GognaNirdosh KumarNK,
pubmed-author:KellerJacquiJ,
pubmed-author:MameghanHedyH,
pubmed-author:MameghanHeidiH,
pubmed-author:MatthewsJohn H LJH,
pubmed-author:SpryNigelN,
pubmed-author:Trans Tasman Radiation Oncology Group,
pubmed-author:TripconyLeeL,
pubmed-author:TurnerSandra LSL
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
81
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
9-17
|
|
pubmed:dateRevised |
2007-7-5
|
|
pubmed:meshHeading |
pubmed-meshheading:17011058-Aged,
pubmed-meshheading:17011058-Aged, 80 and over,
pubmed-meshheading:17011058-Antineoplastic Agents,
pubmed-meshheading:17011058-Carcinoma, Transitional Cell,
pubmed-meshheading:17011058-Cisplatin,
pubmed-meshheading:17011058-Combined Modality Therapy,
pubmed-meshheading:17011058-Cystectomy,
pubmed-meshheading:17011058-Epidemiologic Methods,
pubmed-meshheading:17011058-Female,
pubmed-meshheading:17011058-Humans,
pubmed-meshheading:17011058-Male,
pubmed-meshheading:17011058-Middle Aged,
pubmed-meshheading:17011058-Neoplasm Invasiveness,
pubmed-meshheading:17011058-Neoplasm Recurrence, Local,
pubmed-meshheading:17011058-Radiation-Sensitizing Agents,
pubmed-meshheading:17011058-Remission Induction,
pubmed-meshheading:17011058-Salvage Therapy,
pubmed-meshheading:17011058-Urinary Bladder Neoplasms
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.
|
|
pubmed:affiliation |
Mater Radiation Oncology Centre, Princess Alexandra Hospital, Brisbane, Qld, Australia. Kumar_gogna@health.qld.gov.au
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
